Howard Stotler

Phase I Study of PARP Inhibitor ABT-888 in Combination with Topotecan in Adults with Refractory Solid Tumors and Lymphomas

Shivaani Kummar, Alice P. Chen, Jiuping Ji et al. · Cancer Research · 2011 · 255 citations

Medicine, Oncology, Pharmacology +17

Accelerated Preclinical Testing Using Transplanted Tumors from Genetically Engineered Mouse Breast Cancer Models

Lyuba Varticovski, Melinda G. Hollingshead, Ana I. Robles et al. · Clinical Cancer Research · 2007 · 54 citations

Medicine, Cancer Biology, Oncology +16

Gene expression profiling of 49 human tumor xenografts from in vitro culture through multiple in vivo passages - strategies for data mining in support of therapeutic studies

Melinda G. Hollingshead, Luke H. Stockwin, Sergio Y. Alcoser et al. · BMC Genomics · 2014 · 42 citations · Full text

Medicine, Cancer Biology, Oncology +17

ARC (NSC 188491) has identical activity to Sangivamycin (NSC 65346) including inhibition of both P-TEFb and PKC

Luke H. Stockwin, Sherry X. Yu, Howard Stotler et al. · BMC Cancer · 2009 · 29 citations · Full text

Medicine, Oncology, Pharmacology +16

Development and Validation of an Immunoassay for Quantification of Topoisomerase I in Solid Tumor Tissues

Thomas D. Pfister, Melinda G. Hollingshead, Robert J. Kinders et al. · PLoS ONE · 2012 · 16 citations · Full text

Medicine, Cancer Biology, Oncology +14